𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gemtuzumab Ozogamicin (Mylotarg) for the Treatment of Acute Myeloid Leukemia – Ongoing Trials

✍ Scribed by Gleissner, Beate ;Schlenk, Richard ;Bornhäuser, Martin ;Berdel, Wolfgang E.

Book ID
121089744
Publisher
S. Karger AG
Year
2007
Tongue
English
Weight
122 KB
Volume
30
Category
Article
ISSN
2296-5270

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemtuzumab ozogamicin in the treatment o
Gemtuzumab ozogamicin in the treatment of acute myeloid leukemia
✍ Francis Giles; Elihu Estey; Susan O'Brien 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 484 KB 👁 2 views

## Abstract Gemtuzumab ozogamicin (GO) is a chemotherapeutic agent that consists of a humanized anti‐CD33 antibody (hP67.6) linked to N‐acetyl‐γ calicheamicin 1,2‐dimethyl hydrazine dichloride, a potent enediyne antitumor antibiotic. GO was approved conditionally by the Federal Drug Administration